CAB Spotlight - Vijaya Jori | Johns Hopkins University Baltimore-India Clinical Trials Unit

CAB Spotlight - Vijaya Jori

Date: 04/01/2022

Community Advisory Boards are key members of research programs. The ACTG Newsletter features Vijaya Jori of the JHU-BJGMC CAB!

We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...

PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...

A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...

This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...

The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other...